Press release:
XO CARE A/S Announces Change of Ownership
Hørsholm, Denmark, July 1, 2026: XO CARE A/S, the Denmark-based dental unit manufacturer, today announced that ownership of the company will transfer to Impilo. The change follows the decision of Kim Sørensen, majority owner and CEO, to retire after successfully leading the business for several decades.
XO CARE was founded in 1951 by Verner Sørensen, father of Kim Sørensen. Kim later assumed leadership of the family business and, over subsequent decades, played a central role in developing XO CARE into the leading company it is today, with a strong reputation for innovation, ergonomics and high-quality dental equipment and instruments. “We have consistently prioritised innovation, ergonomics and product quality, and I am proud of what the company and its people have achieved. I am happy to pass the ownership to Impilo as the new owner because I am confident, they will continue this journey”, said Kim Sørensen.
“The priorities that have defined XO CARE – innovation, ergonomics and product quality remain, and we look forward to the journey ahead with our team, customers and partners and Impilo”, said Mark Hvidberg da Silva, who following the change in ownership formally takes the step from Deputy CEO to CEO. Kim Sørensen will remain involved with the company in an advisory capacity while leadership will otherwise remain unchanged.
The terms of the transaction were not disclosed.
About XO CARE A/S: Founded in 1951 and headquartered in Hørsholm, Denmark, XO CARE is a premium designer and manufacturer of dental treatment units. Over its 75-year history, XO CARE has launched multiple new innovations, including the world’s only fully digital dental unit, XO FLOW. XO CARE focuses on design, ergonomics, digital integration and a long lifetime, positioning itself as the premium choice in the market. XO CARE operates through a network of 88 trained XO Certified Partners responsible for sales, installation and servicing of units across 28 countries, with a primary focus in Europe.
About Impilo: Impilo is a Nordic investment company focused solely on investments in lower-mid-market Nordic healthcare companies. It seeks majority buyouts of privately held companies across the pharmaceuticals, MedTech, specialist pharma services and other healthcare & related services industries. Target companies must contribute to the positive and sustainable development of the markets in which they operate, as well as have a credible path to becoming a market leader in their respective niche. Impilo has a well-diversified portfolio of healthcare investments and manages approximately EUR 2 billion of capital from leading international investors.
Media Contact
Mark Hvidberg da Silva, CEO, mds@xo-care.com, +45 61 63 56 00